Mammography Screening Guidelines in 2026: Why the Recommendations Still Differ
U.S. screening recommendations now agree on starting mammography at age 40, but major organizations still differ on screening…
FDA's latest MQSA scorecard shows DBT at nearly 95% of certified mammography facilities, more than 44.8 million annual procedures and strong inspection compliance nationwide....
FDA has proposed moving digital breast tomosynthesis systems from Class III to Class II. Here is what the change could mean for manufacturers and mammography facilities—and what would remain unchanged....
Newly cleared AI software can detect and quantify breast arterial calcification on mammograms. The technology may support cardiovascular-risk conversations, but practices need clear reporting and referral pathways....